People of color are less likely than others to receive timely treatment for medical issues. This is reflected in Covid-19 vaccination numbers, in cancer treatment, and in clinical trial participation. Experts discuss ways to increase participation, especially in clinical trials that might ultimately raise trust in medicine.
- Dr. Lance Okeke, Asst. Prof. of Medicine and Infectious Diseases, Duke Univ
- Dana Dornsife, founder and CEO, Lazarex Cancer Foundation
- Mike McDaniel, participant in ACTIV-2 clinical trial.